TheraRadar
← Back
Data updated: Jul 17, 2026

VERSAPHARM INC

Pharma
Immunology

VERSAPHARM INC is a pharmaceutical company focused on Immunology.

-
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

VERSAPHARM INC's Key Drugs

VERSAPHARM INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

VERSAPHARM INC's Recent FDA Approvals

New NDA/BLA approvals for VERSAPHARM INC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

VERSAPHARM INC's Therapeutic Areas

VERSAPHARM INC's approved drugs and pipeline span 1 therapeutic area, led by Immunology. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Immunology 100%
1 drugs

VERSAPHARM INC's Top Competitors

VERSAPHARM INC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and AbbVie. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.

Pfizer big-pharma
Immunology
Novartis big-pharma
Immunology
AbbVie big-pharma
Immunology
Johnson & Johnson big-pharma
Immunology
GSK big-pharma
Immunology

VERSAPHARM INC Pipeline Snapshot

Active clinical trials for VERSAPHARM INC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Immunology pipeline focus
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling